DEFA14A ·Filed Apr 10, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine annual meeting with no significant changes or financial implications. Shareholders should review the proxy statement for details on executive compensation and board matters, but no immediate action is required.
Final — all horizons settled through T+60d
KURA ▲ +38.99% at T+60d
NEUTRAL call ✓ call won +38.99% · α vs SPY +30.07% · entry $8.72 → $12.12
T+1d
+4.82%
call +4.82% · α +3.61%
$9.14
settled 6mo ago
T+5d
+12.16%
call +12.16% · α +8.86%
$9.78
settled 6mo ago
T+20d
+9.06%
call +9.06% · α +1.33%
$9.51
settled 5mo ago
T+60d
+38.99%
call +38.99% · α +30.07%
$12.12
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Kura Oncology is holding its annual shareholder meeting to vote on director elections, auditor appointment, executive compensation, and equity plan amendments. This is a routine filing with no material financial impact.
Key Facts
- Kura Oncology is holding its annual shareholder meeting on June 4, 2026
- Shareholders will vote on the election of three Class III directors
- The board recommends ratification of Ernst & Young as independent auditors
- The board recommends approval of executive compensation (Say-on-Pay)
- The board recommends approval of amendments to the 2014 Equity Incentive Plan and 2015 Employee Stock Purchase Plan
Financial Impact
No material financial impact
Risk Factors
- None identified - this is a standard annual meeting with no controversial proposals
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-151363 |
| Document: 0001193125-26-151363-index-headers.html | 0001193125-26-151363 |
| Document: 0001193125-26-151363-index.html | 0001193125-26-151363 |
| Document: 0001193125-26-151363.txt | 0001193125-26-151363 |
21 reports for KURA
83% Hit rate best @ T+60▲ +52.28%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $12.09 $11.37 | ▼ −6.00% | ▼ −5.66% | $10.65 (−11.91%) |
Sep 8, 2026 24d ago | 8-K | $12.52 $11.30 | ▼ −9.74% | ▼ −8.63% | $10.65 (−14.94%) |
Aug 24, 2026 5w ago | Insider Cluster | $12.40 $12.65 | ▲ +2.02% | ▲ +1.55% | $10.65 (−14.11%) |
Aug 21, 2026 6w ago | Insider Cluster | $11.89 $12.66 | ▲ +6.48% | ▲ +6.00% | $10.65 (−10.43%) |
Aug 17, 2026 6w ago | Insider Buy | $12.33 $13.59 | ▲ +10.22% | ▲ +10.42% | $10.65 (−13.63%) |
Aug 12, 2026 7w ago | Press Release | $10.09 $11.71 | ▲ +16.06% | ▲ +18.02% | $10.65 (+5.55%) |
Aug 5, 2026 8w ago | Press Release | $9.20 $9.94 | ▲ +8.04% | ▲ +7.69% | $10.65 (+15.76%) |
Jul 29, 2026 9w ago | 8-K | $9.31 $9.28 | ▼ −0.32% | ▼ −3.94% | $10.65 (+14.39%) |
Jul 14, 2026 11w ago | Press Release | $11.24 $10.68 | ▼ −4.98% | ▼ −3.69% | $10.65 (−5.25%) |
Jun 3, 2026 17w ago | Press Release | $8.66 $8.68 | ▲ +0.29% | ▲ +4.11% | $10.65 (+23.05%) |
Showing 10 of 21
US Market Status
Market Closed — Opens Mon (64h 2m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access